# TechAccel

TechAccel is a Private Equity based in Shawnee Mission, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Shawnee Mission, United States
- **Region:** North America
- **Address:** Shawnee Mission, KS, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** www.techaccel.net
- **LinkedIn:** https://www.linkedin.com/company/technology-acceleration-partners-llc

## Regulatory record

- **Reports private funds:** No

## About

TechAccel is a private equity firm based in Shawnee Mission, Kansas. It focuses on venture capital investments. The firm has a team of 12, with one investment professional.

## Sectors

- AgriTech & FoodTech
- Animal Health
- Crop Science
- ClimateTech

## People

- Michael Helmstetter — President and CEO

## Questions

### Who runs investment decisions at TechAccel?

Michael Helmstetter, the founder, serves as President and CEO and leads investment decisions. He brought two decades of experience from MRIGlobal, a not-for-profit contract research organization, where he had overseen agriculture and life-sciences programs. The firm operates with a lean senior team that makes consensus calls on which university technologies to license and fund.

### How does TechAccel source proprietary deal flow?

The firm does not rely on conventional inbound pitch decks. It maintains active relationships with university tech-transfer offices, particularly at land-grant institutions in the Midwest, and proactively scans invention disclosures in crop science, biologicals, and animal health. Once it identifies a promising technology, TechAccel negotiates an exclusive license and funds the proof-of-concept work internally before recruiting a management team to spin out the new company.

### Is TechAccel structured as a venture capital firm or an operating company?

It is a hybrid. The core entity functions as an investment firm that launches and funds startups, but it also operates wholly owned subsidiaries like Reliance Animal Health, which sells pet-health products directly to consumers. That structure allows TechAccel to capture both equity upside from venture creation and operating income from commercialization.

### What investment stages does TechAccel typically target?

TechAccel invests at the very earliest stage — often pre-revenue and pre-management team. The firm licenses a technology, funds the translational science, files provisional patents, and only then recruits a CEO to run the startup. It will continue to provide follow-on capital as the company matures toward a Series A or trade sale.

### Which sectors does TechAccel explicitly avoid?

The firm stays within agriculture, animal health, and biologicals, and does not invest in human therapeutics, medical devices, or general enterprise software. It avoids sectors outside its scientific competency and institutional network, which are concentrated in crop science and veterinary medicine.

## Related profiles

- [Tecexec](https://altss.com/profile/tecexec)
- [TechAccel Ventures](https://altss.com/profile/techaccel-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/techaccel

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology